Measurement of amyloid-β 1–42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST-Reference-Cited by-同舟云学术

Measurement of amyloid-β 1–42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST

Published:2023-04-03 Issue:9 Volume:61 Page:e182-e185
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Dimopoulos Konstantinos¹^ORCID,Simonsen Anja Hviid²,Gramkow Mathias Holsey²,Schrøder Mette¹,Jørgensen Niklas Rye¹³,Rode Line¹,Schmidt Ruth Frikke¹³,Hilsted Linda¹,Hasselbach Steen Gregers²³

Affiliation:

1. Department of Clinical Biochemistry , Copenhagen University Hospital – Rigshospitalet , Copenhagen , Denmark

2. Danish Dementia Research Centre, Department of Neurology , Copenhagen University Hospital – Rigshospitalet , Copenhagen , Denmark

3. Department of Clinical Medicine , Copenhagen University , Copenhagen , Denmark

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2023-0191/pdf

Reference11 articles.

1. Motter, R, Vigo-Pelfrey, C, Kholodenko, D, Barbour, R, Johnson-Wood, K, Galasko, D, et al.. Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease. Ann Neurol 1995;38:643–8. https://doi.org/10.1002/ana.410380413.

2. Andreasen, N, Blennow, K. β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease. Peptides 2002;23:1205–14. https://doi.org/10.1016/s0196-9781(02)00056-6.

3. Hansson, O, Rutz, S, Zetterberg, H, Bauer, E, Hähl, T, Manuilova, E, et al.. Pre-analytical protocol for measuring Alzheimer’s disease biomarkers in fresh CSF. Alzheimers Dement (Amst) 2020;12:1–11.

4. Schindler, SE, Sutphen, CL, Teunissen, C, McCue, LM, Morris, JC, Holtzman, DM, et al.. Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years. Alzheimer’s Dementia 2018;14:62–70. https://doi.org/10.1016/j.jalz.2017.06.2264.

5. Tijms, BM, Willemse, EAJ, Zwan, MD, Mulder, SD, Visser, PJ, Van Berckel, BNM, et al.. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-β 1–42 analysis results. Clin Chem 2018;64:576–85. https://doi.org/10.1373/clinchem.2017.281055.